Systemic Investigation Identifying Salivary miR-196b as a Promising Biomarker for Early Detection of Head-Neck Cancer and Oral Precancer Lesions.
Ann-Joy ChengGuo-Rung YouChe-Jui LeeYa-Ching LuShang-Ju TangYi-Fang HuangYu-Chen HuangLi-Yu LeeKang-Hsing FanYen-Chao ChenShiang-Fu HuangJoseph Tung-Chieh ChangPublished in: Diagnostics (Basel, Switzerland) (2021)
Salivary miR-196b could be an excellent biomarker for diagnosing OPC and early detection of HNSC. This molecule may be used for early screening high-risk groups of HNSC.